HomeInsightsStock Comparison

Caplin Point Laboratories Ltd vs Dr Reddys Laboratories Ltd Stock Comparison

Caplin Point Laboratories Ltd vs Dr Reddys Laboratories Ltd Stock Comparison

Last Updated on: May 25, 2025

Key Highlights

  • The Latest Trading Price of Caplin Point Laboratories Ltd is ₹ 2193 as of 23 May 15:30.
  • The P/E Ratio of Caplin Point Laboratories Ltd changed from 9.9 on March 2020 to 21.9 on March 2024 . This represents a CAGR of 17.21% over 5 yearsThe P/E Ratio of Dr Reddys Laboratories Ltd changed from 25.6 on March 2020 to 18.4 on March 2024 . This represents a CAGR of -6.39% over 5 years.
  • The Market Cap of Caplin Point Laboratories Ltd changed from ₹ 2135 crore on March 2020 to ₹ 10003 crore on March 2024 . This represents a CAGR of 36.18% over 5 yearsThe Market Cap of Dr Reddys Laboratories Ltd changed from ₹ 51797 crore on March 2020 to ₹ 102679 crore on March 2024 . This represents a CAGR of 14.67% over 5 years.
  • The revenue of Caplin Point Laboratories Ltd for the Mar '25 is ₹ 528.27 crore as compare to the Dec '24 revenue of ₹ 524.32 crore. This represent the growth of 0.75% The revenue of Dr Reddys Laboratories Ltd for the Mar '25 is ₹ 9056 crore as compare to the Dec '24 revenue of ₹ 8535 crore. This represent the growth of 6.1%.
  • The ebitda of Caplin Point Laboratories Ltd for the Mar '25 is ₹ 193.88 crore as compare to the Dec '24 ebitda of ₹ 193.64 crore. This represent the growth of 0.12% The ebitda of Dr Reddys Laboratories Ltd for the Mar '25 is ₹ 2525 crore as compare to the Dec '24 ebitda of ₹ 2427 crore. This represent the growth of 4.04%.
  • The net profit of Caplin Point Laboratories Ltd changed from ₹ 104.23 crore to ₹ 145.28 crore over 8 quarters. This represents a CAGR of 18.06% The net profit of Dr Reddys Laboratories Ltd changed from ₹ 1405 crore to ₹ 1586 crore over 8 quarters. This represents a CAGR of 6.27% .
  • The Dividend Payout of Caplin Point Laboratories Ltd changed from 9.57 % on March 2020 to 13.39 % on March 2024 . This represents a CAGR of 6.95% over 5 yearsThe Dividend Payout of Dr Reddys Laboratories Ltd changed from 14.14 % on March 2020 to 15.37 % on March 2024 . This represents a CAGR of 1.68% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Caplin Point Laboratories Ltd

  • Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16th, 1990.
  • The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
  • Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
  • It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
  • In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.

About Dr Reddys Laboratories Ltd

  • Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
  • Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
  • The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
  • Dr. Reddy's operates in markets across the globe.
  • Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories Limited was incorporated in 1984 in Hyderabad.

Caplin Point Laboratories Ltd News Hub

News

Board of Caplin Point Laboratories recommends dividend

Caplin Point Laboratories announced that the Board of Directors of the Company at its meet...

Read more

15 May 2025 14:05

News

Caplin Steriles receives USFDA approval for Haloperidol Decanoate Injection

Caplin Steriles (Caplin), a Subsidiary Company of Caplin Point Laboratories, has been gran...

Read more

14 May 2025 14:27

News

Caplin Point Labs subsidiary gets US FDA nod for schizophrenia treatment drug Haloperidol

The approved drug is a generic therapeutic equivalent version of the reference listed drug...

Read more

14 May 2025 13:20

News

Caplin Point Laboratories to conduct board meeting

Caplin Point Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

08 May 2025 14:47

News

Caplin Point Laboratories to conduct board meeting

Caplin Point Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

07 May 2025 17:18

News

Caplin Steriles receives USFDA approval for Phytonadione Injectable Emulsion

Caplin Point Laboratories announced that its subsidiary, Caplin Steriles, has been granted...

Read more

23 Apr 2025 12:59

Dr Reddys Laboratories Ltd News Hub

News

DRL's USA facility gets 2 observations from USFDA

The USFDA completed aforementioned inspection and issued form-483 with two observations. H...

Read more

19 May 2025 08:32

News

USFDA completes GMP inspection of Dr Reddy's Middleburgh facility in New York

Dr Reddys Laboratories announced that the United States Food & Drug Administration (USFDA)...

Read more

17 May 2025 11:32

News

Dr Reddys Lab jumps after Q4 PAT rises 22% YoY

Revenue from operations rose 20% year-on-year to Rs 8,506 crore, compared to Rs 7,083 cror...

Read more

12 May 2025 14:50

News

Dr Reddys Laboratories AGM scheduled

Dr Reddys Laboratories announced that the 41th Annual General Meeting(AGM) of the company ...

Read more

10 May 2025 10:17

News

Dr Reddys Lab Q4 PAT rises 22% YoY

Revenue from operations rose 20% year-on-year to Rs 8,506 crore, compared to Rs 7,083 cror...

Read more

10 May 2025 10:52

News

Board of Dr Reddys Laboratories recommends Final Dividend

Dr Reddys Laboratories announced that the Board of Directors of the Company at its meeting...

Read more

09 May 2025 17:01

SWOT Analysis Of Caplin Point Laboratories Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Caplin Point Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Dr Reddys Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Caplin Point Laboratories Ltd and Dr Reddys Laboratories Ltd

Which company has a larger market capitalization, Caplin Point Laboratories Ltd or Dr Reddys Laboratories Ltd?

Market cap of Caplin Point Laboratories Ltd is 16,674 Cr while Market cap of Dr Reddys Laboratories Ltd is 102,617 Cr

What are the key factors driving the stock performance of Caplin Point Laboratories Ltd and Dr Reddys Laboratories Ltd?

The stock performance of Caplin Point Laboratories Ltd and Dr Reddys Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Caplin Point Laboratories Ltd and Dr Reddys Laboratories Ltd?

As of May 25, 2025, the Caplin Point Laboratories Ltd stock price is INR ₹2193.65. On the other hand, Dr Reddys Laboratories Ltd stock price is INR ₹1229.75.

How do dividend payouts of Caplin Point Laboratories Ltd and Dr Reddys Laboratories Ltd compare?

To compare the dividend payouts of Caplin Point Laboratories Ltd and Dr Reddys Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions